Cigna Corp. plans to expand a system that uses artificial intelligence to identify gaps in treatment of chronic diseases, such as patients skipping their medications, and deliver personalized recommendations for specific patients.
The product, called Health Connect 360, integrates data from a combination of sources and analytical tools, some developed at Cigna and others brought in as part of its $54 billion acquisition of pharmacy-benefit manager Express Scripts Holding Co., completed late last year. Express Scripts, which began developing the service two years ago, rolled out portions of it to some customers this year.
Cigna is already using AI to predict whether patients might abuse or overdose on prescription opioids.
More
1 comment:
I know someone who regularly abuses their opiates , and drives all around Salisbury and Cambridge ...
often wrecking their vehicles, and insurance buys em another
Post a Comment